The DCGI has suspended Entod Pharmaceuticals' permission to manufacture and sell eye drops claimed to reduce dependency on reading glasses for presbyopia. The suspension follows the company's unapproved claims about the product's benefits. Entod plans to challenge the decision in court, asserting no unethical presentation of facts was made.
